These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 12970746

  • 1. Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.
    Lee SO, Lou W, Hou M, Onate SA, Gao AC.
    Oncogene; 2003 Sep 11; 22(39):7981-8. PubMed ID: 12970746
    [Abstract] [Full Text] [Related]

  • 2. Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein.
    Steely AM, Willoughby JA, Sundar SN, Aivaliotis VI, Firestone GL.
    Anticancer Drugs; 2017 Oct 11; 28(9):1018-1031. PubMed ID: 28708672
    [Abstract] [Full Text] [Related]

  • 3. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.
    Lee SO, Lou W, Nadiminty N, Lin X, Gao AC.
    Prostate; 2005 Jul 01; 64(2):160-7. PubMed ID: 15678501
    [Abstract] [Full Text] [Related]

  • 4. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X, Choi RY, Jawad SM, Arnold JT.
    Prostate; 2011 May 15; 71(7):766-77. PubMed ID: 21031436
    [Abstract] [Full Text] [Related]

  • 5. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
    Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH, Wu CT, Chang C.
    J Biol Chem; 2005 Sep 30; 280(39):33558-65. PubMed ID: 16061480
    [Abstract] [Full Text] [Related]

  • 6. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM, Malik SN, Bedolla RG, Wang Y, Mikhailova M, Prihoda TJ, Troyer DA, Kreisberg JI.
    Endocr Relat Cancer; 2005 Mar 30; 12(1):119-34. PubMed ID: 15788644
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T, Wang LH, Farrar WL.
    Cancer Res; 2000 Apr 15; 60(8):2132-5. PubMed ID: 10786674
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ.
    Mol Cell Endocrinol; 2004 May 31; 220(1-2):109-23. PubMed ID: 15196705
    [Abstract] [Full Text] [Related]

  • 9. Androgen receptor signaling: mechanism of interleukin-6 inhibition.
    Jia L, Choong CS, Ricciardelli C, Kim J, Tilley WD, Coetzee GA.
    Cancer Res; 2004 Apr 01; 64(7):2619-26. PubMed ID: 15059919
    [Abstract] [Full Text] [Related]

  • 10. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K, Eder IE, Putz T, Ramoner R, Culig Z, Ueberall F, Bartsch G, Klocker H.
    Prostate; 2004 Feb 15; 58(3):259-68. PubMed ID: 14743465
    [Abstract] [Full Text] [Related]

  • 11. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ, Willard MT, Frederickson CE, Zhong H, Simons JW.
    Clin Cancer Res; 2003 Jul 15; 9(7):2416-25. PubMed ID: 12855613
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-4 in patients with prostate cancer.
    Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M, Suyama T, Imamoto T, Komiya A, Yukio N, Ichikawa T.
    Anticancer Res; 2005 Jul 15; 25(6C):4595-8. PubMed ID: 16334148
    [Abstract] [Full Text] [Related]

  • 13. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
    Liu S, Vinall RL, Tepper C, Shi XB, Xue LR, Ma AH, Wang LY, Fitzgerald LD, Wu Z, Gandour-Edwards R, deVere White RW, Kung HJ.
    Oncogene; 2008 Jan 17; 27(4):499-505. PubMed ID: 17653089
    [Abstract] [Full Text] [Related]

  • 14. Roles of methyltrienolone (R1881) in AKTs and AR expression patterns of cultured granulosa-lutein cells.
    Nekoonam S, Naji M, Mortezaee K, Amidi F.
    J Cell Biochem; 2018 Sep 17; 119(9):7204-7211. PubMed ID: 29749659
    [Abstract] [Full Text] [Related]

  • 15. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.
    Liao X, Thrasher JB, Pelling J, Holzbeierlein J, Sang QX, Li B.
    Endocrinology; 2003 May 17; 144(5):1656-63. PubMed ID: 12697668
    [Abstract] [Full Text] [Related]

  • 16. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts.
    Kang HY, Cho CL, Huang KL, Wang JC, Hu YC, Lin HK, Chang C, Huang KE.
    J Bone Miner Res; 2004 Jul 17; 19(7):1181-90. PubMed ID: 15177002
    [Abstract] [Full Text] [Related]

  • 17. Androgen receptor levels are upregulated by Akt in prostate cancer.
    Ha S, Ruoff R, Kahoud N, Franke TF, Logan SK.
    Endocr Relat Cancer; 2011 Apr 17; 18(2):245-55. PubMed ID: 21317204
    [Abstract] [Full Text] [Related]

  • 18. AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
    Li P, Lee H, Guo S, Unterman TG, Jenster G, Bai W.
    Mol Cell Biol; 2003 Jan 17; 23(1):104-18. PubMed ID: 12482965
    [Abstract] [Full Text] [Related]

  • 19. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
    Lin HK, Yeh S, Kang HY, Chang C.
    Proc Natl Acad Sci U S A; 2001 Jun 19; 98(13):7200-5. PubMed ID: 11404460
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.
    Lin DL, Whitney MC, Yao Z, Keller ET.
    Clin Cancer Res; 2001 Jun 19; 7(6):1773-81. PubMed ID: 11410519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.